Investor Relations
  • ABCD3 R$ 00,00 0,00%
  • ABCD3 R$ 00,00 0,00%
A+ A-
Corporate PTEN

Historic

1936

Foundation of the Silver Laboratory

1970

Acquisition of the Prata Laboratory by João Marques de Paulo.

1973

Acquisition of the Embu-Guaçu Unit (SP)

1980

Beginning of activities as the National Chemical Pharmaceutical Union.

1983

Start of activities at the graphic park in Embu-Guaçu (SP)

1998

Acquisition of the Searle line, with emphasis on the brand Vodol® Leader in the antimycotic market.

2000

  • Acquisition of the Agener veterinary laboratory
  • creation of the Animal Health Division.
  • Start of operations in Pouso Alegre (MG)

2003

Acquisition of the Genom Laboratory, creation of the Medical Prescription Division

2006

Start of activities at the Brasília (DF) plant

2007

Acquisition of the Bio Macro Laboratory

2010

Acquisition of the Tecnopec Laboratory. Agener enters the Animal Reproduction market.

2012

  • Acquisition of Bthek Biotecnologia – Brasília DF
  • Creation of the Bionovis company, focused on biotechnology, in partnership with 3 other large pharmaceutical companies

2015

Acquisition of the Novartis industrial complex in Taboão da Serra (SP), renamed Anovis

2017

Acquisition of the Zoetis industrial complex, in Guarulhos SP, renamed Inovat

2018

Inauguration of the logistics center and graphic park, in Pouso Alegre (MG)

2018

Acquisition of Elanco's biotechnology plant (Eli Lilly) in Georgia (United States), changing its name to Union Agener

2020

Acquisition of the Neocopan® brand

2021

Acquisition of the Laboratil manufacturing plant

2021

Launch of the Program with a goal of planting 1 million native trees within 5 years

2021

Acquisition of Slow-K brands. Xantinon®, market-leading Xantinon Complex® hepatoprotectors

2022

Acquisition of the industrial complex of Bayer – São Paulo SP Leadership in oral contraceptives in Latin America, highlighting the Ciclo 21® and Microvlar® brands